• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

GSK LA interviews









It is my impression that if you had a second interview after the panel you are most likely the choice. The second interview was to have a second sign off on the panels choice following.the first interview. No formal offers are being communicated until after drug approval -.fda review is.reportedly next week.